Fundraising FoxReven Pharmaceuticals
Sarasota, US · Florida corporation
Find your way into Reven Pharmaceuticals
Sign up to see every warm intro you have to Reven Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Reven Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Reven is a biotech company developing RJX technology to address treatment needs for patients with limited therapeutic options. The company has conducted over a decade of research, including FDA-approved clinical studies and is currently investigating the technology's applications across multiple treatment modalities.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$6.3M disclosed across 2 rounds · 2013–2014
▶$4.4MraisedFeb 2015 · 48 investors · PharmaceuticalsRule 506(b)
- Peter B. LangeExecutive Officer, Director
- Brian DenommeExecutive Officer, Director
- Michael A. VolkExecutive Officer
- Michael HandleyExecutive Officer
- Offering amount
- $7M
- Amount sold
- $4.4M
- Minimum investment
- $50K
- Proceeds to insiders
- $850K
- First sale
- Jan 2014
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$1.8MraisedJan 2014 · 36 investors · PharmaceuticalsRule 506(b)
- Peter B. LangeExecutive Officer, Director
- Brian DenommeExecutive Officer, Director
- Michael HandleyExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.8M
- Minimum investment
- $5K
- Proceeds to insiders
- $54K
- Placement agents
- Futures Investment Company
- First sale
- Feb 2013
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Reven Pharmaceuticals went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Reven Pharmaceuticals.
Frequently asked questions
- What does Reven Pharmaceuticals do?
- Reven is a biotech company developing RJX technology to address treatment needs for patients with limited therapeutic options. The company has conducted over a decade of research, including FDA-approved clinical studies and is currently investigating the technology's applications across multiple treatment modalities.
- How much funding has Reven Pharmaceuticals raised?
- Reven Pharmaceuticals has disclosed $6.3M raised across 2 rounds.
- Where is Reven Pharmaceuticals headquartered?
- Reven Pharmaceuticals is headquartered in Sarasota, US.